Duane Nash insider trades: Immunic (IMUX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Duane reports to the SEC
Open-market buys and sales
19 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 13, 2025 | IMUX | ↑ Buy | 20,000 | $0.83 | $17K | Direct | Jun 16, 2025 (3d) |
| May 12, 2022 | IMUX | ↑ Buy | 10,000 | $5.03 | $50K | Direct | May 13, 2022 (1d) |
| Aug 10, 2021 | IMUX | ↑ Buy | 1,000 | $9.80 | $10K | Direct | Aug 11, 2021 (1d) |
| May 12, 2021 | IMUX | ↑ Buy | 4,000 | $12.75 | $51K | Direct | May 12, 2021 (0d) |
| Dec 4, 2019 | IMUX | ↓ Sell10b5-1 | 4,400 | $6.96 | $31K | Direct | Dec 4, 2019 (0d) |
| Feb 15, 2018 | AKBA | ↓ Sell | 1,000 | $14.62 | $15K | Direct | Feb 16, 2018 (1d) |
| Oct 2, 2017 | AKBA | ↓ Sell10b5-1 | 1,188 | $19.64 | $23K | Direct | Oct 4, 2017 (2d) |
| Jul 3, 2017 | AKBA | ↓ Sell10b5-1 | 990 | $14.27 | $14K | Direct | Jul 6, 2017 (3d) |
| Jun 8, 2017 | VTL | ↑ Buy | 3,900 | $3.12 | $12K | Direct | Jun 9, 2017 (1d) |
| Apr 3, 2017 | AKBA | ↓ Sell10b5-1 | 991 | $9.20 | $9K | Direct | Apr 4, 2017 (1d) |
| Jan 3, 2017 | AKBA | ↓ Sell10b5-1 | 1,980 | $10.46 | $21K | Direct | Jan 3, 2017 (0d) |
| Oct 3, 2016 | AKBA | ↓ Sell10b5-1 | 1,981 | $8.96 | $18K | Direct | Oct 4, 2016 (1d) |
| Jul 6, 2016 | AKBA | ↓ Sell10b5-1 | 1,980 | $7.48 | $15K | Direct | Jul 7, 2016 (1d) |
| Oct 2, 2015 | AKBA | ↓ Sell10b5-1 | 996 | $8.65 | $9K | Direct | Oct 5, 2015 (3d) |
| Jul 2, 2015 | AKBA | ↓ Sell10b5-1 | 996 | $9.53 | $9K | Direct | Jul 6, 2015 (4d) |
| Apr 2, 2015 | AKBA | ↓ Sell10b5-1 | 996 | $9.09 | $9K | Direct | Apr 6, 2015 (4d) |
| Jan 2, 2015 | AKBA | ↓ Sell10b5-1 | 995 | $11.46 | $11K | Direct | Jan 5, 2015 (3d) |
| Dec 26, 2014 | AKBA | ↓ Sell10b5-1 | 11,933 | $11.23 | $134K | Direct | Dec 29, 2014 (3d) |
| Oct 8, 2014 | VTL | ↑ Buy | 100 | $17.50 | $2K | Direct | Oct 9, 2014 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Duane Nash's insider trades
Duane Nash is Executive Chairman at Immunic (IMUX). Since Oct 8, 2014, Duane has reported 6 open-market purchases worth $142K and 13 sales worth $318K on SEC Form 4. There have been no open-market trades in the last 12 months.
12 sales (95% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (24 filings), shares returned to the company (2 filings), gifts (1 filing), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IMUX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.